Evidence map›Paper›PMID 42427860›Full record

ArticleResearch square2026

Real-world performance of large-scale propensity score adjustment strategies: Matching, weighting, and stratification.

Kelly M Li, Martijn J Schuemie, Patrick B Ryan, Linying Zhang, Yong Chen, Kashish Priyam, Nicole Pratt, George Hripcsak, Marc A Suchard

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kelly M LiDepartment of Biostatistics, University of California, Los Angeles, Los Angeles, CA, USA.
Martijn J SchuemieDepartment of Biostatistics, University of California, Los Angeles, Los Angeles, CA, USA.
Patrick B RyanJanssen Research and Development, Raritan, NJ, USA.
Linying ZhangInstitute for Informatics, Data Science and Biostatistics, Department of Medicine, Washington University in St Louis, St Louis, Missouri, USA.
Yong ChenDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Kashish PriyamDepartment of Biostatistics, University of California, Los Angeles, Los Angeles, CA, USA.
Nicole PrattQuality Use of Medicines and Pharmacy Research Centre, University of South Australia, Adelaide, Australia.
George HripcsakDepartment of Biomedical Informatics, Columbia University Medical Center, New York, NY, USA.
Marc A SuchardDepartment of Biostatistics, University of California, Los Angeles, Los Angeles, CA, USA.

Funding

Real-world Evidence to Inform Decisions for Hypertension Treatment EscalationR01HL169954 · NHLBI · YALE UNIVERSITY · PI Yuan Lu · 2023 to 2026
$2.6M
Translating Personalized Inference from Randomized Clinical Trials to Real-World Cardiovascular CareR01HL167858 · NHLBI · YALE UNIVERSITY · PI Rohan Khera · 2024 to 2026
$2.3M
NHLBI NIH HHS R01 HL167858NHLBI NIH HHS R01 HL169954
6 · The paper itself

Abstract

Objective: 1.1Propensity score (PS) models are commonly used for addressing confounding in observational studies. Researchers are increasingly incorporating large numbers of covariates into PS models, using techniques like large-scale propensity score (LSPS) adjustment. It remains unclear if the inclusion of many covariates affects the subsequent choice of adjustment strategy. Methods: 1.2In this paper, we evaluate commonly used adjustment strategies using large-scale models, including matching, stratification, and inverse probability of treatment weighting (IPTW), to estimate treatment effects under a new-user cohort design. Evaluations employ real-world data across four national healthcare databases and incorporate 3,840 treatment effect estimates per model specification for 24 different treatment cohort comparisons against 160 negative control outcomes. We assess adjustment strategies for covariate balance between treatment cohorts and type-I and type-II error, mean-squared error, and precision of the adjusted effect estimate. Results: 1.3Across all model specifications, IPTW with symmetric Crump trimming and 1:1 matching perform best overall, achieving strong balance and low bias. Additionally, empirical calibration of effect estimates can substantially reduce differences between strategies. Discussion: 1.4No single strategy is clearly superior in all settings. We recommend incorporating the top-performing strategies at least as sensitivity analyses in studies even if researchers anticipate that some other strategy may excel due to expectation of their study's operating characteristics. We also recommend use of diagnostics like covariate balance to check strategy performance. Conclusion: 1.5IPTW with Crump trimming and 1:1 matching are strong default choices for large-scale PS adjustment, but strategy selection should be guided by study context and validated with balance and error diagnostics. We broadly recommend empirical calibration to reduce sensitivity to model choice.

Indexed as

observational studypropensity scorereal-world data

Identifiers

PMID42427860
PMCPMC13345525

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.